Kestra Medical Technologies (KMTS) Other Accumulated Expenses (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Other Accumulated Expenses data on file, last reported at $6.1 million in Q1 2026.

• Other Accumulated Expenses for Q1 2026 came in at $6.1 million, up 76.94% year-over-year; the trailing twelve-month figure through Jan 2026 was $6.1 million (up 76.94% YoY), and the FY2025 annual result was $3.5 million, up 197.82% from the prior year.
• Other Accumulated Expenses rose to $6.1 million in Q1 2026 per KMTS's latest filing, from $5.3 million in the prior quarter.
• Over five years, Other Accumulated Expenses peaked at $6.1 million in Q1 2026 and troughed at $1.2 million in Q2 2024.
• A 3-year average of $4.1 million and a median of $4.3 million in 2025 frame the typical range for Other Accumulated Expenses.
• The sharpest annual moves came in 2025 and 2026: Other Accumulated Expenses surged 197.82% in 2025, then surged 76.94% in 2026.
• A 3-year view of Other Accumulated Expenses shows it stood at $1.2 million in 2024, then surged by 348.87% to $5.3 million in 2025, then climbed by 14.09% to $6.1 million in 2026.
• Business Quant data shows KMTS's Other Accumulated Expenses at $6.1 million in Q1 2026, $5.3 million in Q4 2025, and $5.1 million in Q3 2025.